Trinity Biotech PLC
NASDAQ:TRIB
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| IE |
|
Trinity Biotech PLC
NASDAQ:TRIB
|
16.9m USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
190.1B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
181.4B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
140.5B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
139.4B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
131.6B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
58.1B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.1B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
54.1B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.4B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
37.1B USD |
Loading...
|
Market Distribution
| Min | -6 913.1% |
| 30th Percentile | 0% |
| Median | 3.1% |
| 70th Percentile | 10.2% |
| Max | 197.7% |
Other Profitability Ratios
Trinity Biotech PLC
Glance View
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The company is headquartered in Bray, Wicklow. The firm's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. The company operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Trinity Biotech PLC is -51.6%, which is below its 3-year median of -47.3%.
Over the last 3 years, Trinity Biotech PLC’s Net Margin has decreased from 1.1% to -51.6%. During this period, it reached a low of -65.6% on Dec 31, 2022 and a high of 1.1% on Dec 31, 2021.
